A Combination of EVI1 and PRDM16 Expression Clarified the Clinical Features of Intermediate/High Risk Patients in Pediatric Acute Myeloid Leukemia

MLA

Kentaro Ohki, et al. “A Combination of EVI1 and PRDM16 Expression Clarified the Clinical Features of Intermediate/High Risk Patients in Pediatric Acute Myeloid Leukemia.” Blood, vol. 126, Dec. 2015, p. 1380. EBSCOhost, https://doi.org/10.1182/blood.v126.23.1380.1380.

APA

Kentaro Ohki, Manabu Sotomatsu, Norio Shiba, Yasuhide Hayashi, Hitoshi Ichikawa, Yusuke Hara, Myoung-ja Park, Genki Yamato, Takashi Taga, Daisuke Tomizawa, Keizo Horibe, Souichi Adachi, Akio Tawa, & Hirokazu Arakawa. (2015). A Combination of EVI1 and PRDM16 Expression Clarified the Clinical Features of Intermediate/High Risk Patients in Pediatric Acute Myeloid Leukemia. Blood, 126, 1380. https://doi.org/10.1182/blood.v126.23.1380.1380

Chicago

Kentaro Ohki, Manabu Sotomatsu, Norio Shiba, Yasuhide Hayashi, Hitoshi Ichikawa, Yusuke Hara, Myoung-ja Park, et al. 2015. “A Combination of EVI1 and PRDM16 Expression Clarified the Clinical Features of Intermediate/High Risk Patients in Pediatric Acute Myeloid Leukemia.” Blood 126 (December): 1380. doi:10.1182/blood.v126.23.1380.1380.